Table 1.
Basic characteristics of HCC patients in Group A and Group C after PSM.
| Characteristic | Group A | Group C | p |
|---|---|---|---|
| n = 10 | n = 20 | ||
| Age (years) | 56.8 ± 6.3 | 55.25 ± 6.9 | 0.56 |
| Sex (Male/Female) | 8/2 | 17/3 | >0.99 |
| Pathologic Diagnosis | |||
| Hepatocellular Carcinoma | 10 | 20 | >0.99 |
| Others | 0 | 0 | >0.99 |
| MVI (0/1/2) | 7/3/0 | 12/7/1 | >0.99 |
| BCLC Stage (A1/A2/A3) | 10/0/0 | 20/0/0 | >0.99 |
| HBV Infection (Positive/Negative) | 10/0 | 20/0 | >0.99 |
| Tumor Location (Liver Segment) | |||
| S8v | 4 | 8 | >0.99 |
| S8d | 1 | 2 | >0.99 |
| S3 | 3 | 6 | >0.99 |
| S4b | 1 | 2 | >0.99 |
| S5 | 1 | 2 | >0.99 |
| Longest Diameter of the Tumor (CM) | 3.13 ± 0.5 | 3.1 ± 0.6 | 0.89 |
| ASA Grade (I/II) | 9/1 | 17/3 | >0.99 |
| Comorbidities | |||
| Hypertension | 1 | 2 | >0.99 |
| Diabetes | 0 | 1 | >0.99 |
| Varicose Vein | 0 | 1 | >0.99 |
| Child Pugh Grade (A/B) | 10/0 | 20/0 | >0.99 |
| Open Conversion (Yes/No) | 0/10 | 0/20 | >0.99 |
MVI, microvascular invasion; BCLC stage, Barcelona Clinic Liver Cancer Stage; ASA Grade, American Society of Anesthesiologists physical status; values are presented as n (%). Fisher’s exact and Student’s t-tests were used, as appropriate; *p < 0.05.